Dermatologic Drug Prices Up Substantially From 2009

This article originally appeared here.
Share this content:
Dermatologic Drug Prices Up Substantially From 2009
Dermatologic Drug Prices Up Substantially From 2009

WEDNESDAY, Nov. 25, 2015 (HealthDay News) -- Between 2009 and 2015, retail prices of brand-name dermatologic drugs rose 401 percent, on average, and generics were up 279 percent between 2011 and 2014, according to research published online Nov. 25 in JAMA Dermatology.

Beginning in 2009, the researchers surveyed four national pharmacy chains -- Costco, CVS, Sam's Club and Walgreens -- in West Palm Beach, Fla., to obtain retail prices for 72 brand-name drugs. Subsequent surveys eventually included 120 brands and their generic equivalents. The final analysis, conducted in August 2015, is based on 19 brand-name drugs and a handful of generics.

Escalating prices were seen across the board. On average, anti-infective medicines (Altabax, Oxistat cream, and Xolegel) rose 309 percent, and corticosteroids such as Cloderm cream and Cutivate lotion increased 290 percent. Acne and rosacea medicines, including Benzaclin and Finacea, jumped 195 percent, and psoriasis drugs such as Oxsoralen-Ultra increased 180 percent on average. A 30-gram tube of generic nystatin-triamcinolone rose from $9.15 in 2011 to $103.88 in 2014, a 10-fold price increase.

"Cancer drugs were the worst in terms of the numbers" -- up 1,240 percent or nearly $11,000 over the six-year study period -- primarily because of two medicines, Steven Rosenberg, M.D., voluntary professor of dermatology at the University of Miami Miller School of Medicine, and senior author of the study, told HealthDay. "But if you look at some of the other products that are prescribed very frequently, they went up, some of them 10-fold just in one year, with no explanation that I can think of."

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

Disabling Injury, Illness Less Likely for Elderly Who Exercise

Disabling Injury, Illness Less Likely for Elderly Who ...

And likely to recover more quickly if injury or illness occurs

More Evidence of Abdominal Fat, Poor Cardiovascular Health Link

More Evidence of Abdominal Fat, Poor Cardiovascular Health ...

Adipose tissue imaging may outperform body mass index for cardiovascular risk assessment

is free, fast, and customized just for you!

Already a member?

Sign In Now »